Standard
Individual and combined glucose-lowering effects of glucagon receptor antagonism and dipeptidyl peptidase-4 inhibition. / Maagensen, H.; Haedersdal, S.; Lund, A.; Nielsen-Hannerup, E.; Holst, J.; Knop, F.; Vilsboll, T.
In:
Diabetologia, Vol. 61, 2018, p. S246-S247.
Research output: Contribution to journal › Conference abstract in journal › Research
Harvard
Maagensen, H, Haedersdal, S, Lund, A, Nielsen-Hannerup, E
, Holst, J, Knop, F & Vilsboll, T 2018, '
Individual and combined glucose-lowering effects of glucagon receptor antagonism and dipeptidyl peptidase-4 inhibition',
Diabetologia, vol. 61, pp. S246-S247.
https://doi.org/10.1007/s00125-018-4693-0
APA
Maagensen, H., Haedersdal, S., Lund, A., Nielsen-Hannerup, E.
, Holst, J., Knop, F., & Vilsboll, T. (2018).
Individual and combined glucose-lowering effects of glucagon receptor antagonism and dipeptidyl peptidase-4 inhibition.
Diabetologia,
61, S246-S247.
https://doi.org/10.1007/s00125-018-4693-0
Vancouver
Maagensen H, Haedersdal S, Lund A, Nielsen-Hannerup E
, Holst J, Knop F et al.
Individual and combined glucose-lowering effects of glucagon receptor antagonism and dipeptidyl peptidase-4 inhibition.
Diabetologia. 2018;61:S246-S247.
https://doi.org/10.1007/s00125-018-4693-0
Author
Maagensen, H. ; Haedersdal, S. ; Lund, A. ; Nielsen-Hannerup, E. ; Holst, J. ; Knop, F. ; Vilsboll, T. / Individual and combined glucose-lowering effects of glucagon receptor antagonism and dipeptidyl peptidase-4 inhibition. In: Diabetologia. 2018 ; Vol. 61. pp. S246-S247.
Bibtex
@article{caa2e4db7baa4f5a83d612a4a018479c,
title = "Individual and combined glucose-lowering effects of glucagon receptor antagonism and dipeptidyl peptidase-4 inhibition",
author = "H. Maagensen and S. Haedersdal and A. Lund and E. Nielsen-Hannerup and J. Holst and F. Knop and T. Vilsboll",
year = "2018",
doi = "10.1007/s00125-018-4693-0",
language = "English",
volume = "61",
pages = "S246--S247",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
}
RIS
TY - ABST
T1 - Individual and combined glucose-lowering effects of glucagon receptor antagonism and dipeptidyl peptidase-4 inhibition
AU - Maagensen, H.
AU - Haedersdal, S.
AU - Lund, A.
AU - Nielsen-Hannerup, E.
AU - Holst, J.
AU - Knop, F.
AU - Vilsboll, T.
PY - 2018
Y1 - 2018
U2 - 10.1007/s00125-018-4693-0
DO - 10.1007/s00125-018-4693-0
M3 - Conference abstract in journal
C2 - 30132038
VL - 61
SP - S246-S247
JO - Diabetologia
JF - Diabetologia
SN - 0012-186X
ER -